← Back to Clinical Trials
Recruiting NCT01186133
Evaluation of the First, Second, and New Drug-Eluting Stents in Routine Clinical Practice
Trial Parameters
Condition Coronary Artery Disease
Sponsor Seung-Jung Park
Study Type OBSERVATIONAL
Phase N/A
Enrollment 50,000
Sex ALL
Min Age 19 Years
Max Age N/A
Start Date 2009-01
Completion 2030-12
Brief Summary
The objective of this study is to evaluate effectiveness and safety of the new drug-eluting stent (DES), as compared with the first-,second-,third-, and fourth-generation DES, in the "real world" daily practice.
Eligibility Criteria
Inclusion Criteria: * coronary disease amenable to percutaneous coronary intervention (PCI) * no clinical and lesion limitations Exclusion Criteria: * patients with a mixture of several DES * terminal illness with life expectancy less than 1 year * patients with cardiogenic shock